View in EDS

Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.

Saved in:
Bibliographic Details
Title: Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.
Authors: Alexandre-Heymann L; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada., Reynaud Q; Service de Médecine Interne et de Pathologie Vasculaire, Hospices Civils de Lyon, Hôpital Lyon Sud, 165 Chemin du Grand Revoyet, Pierre-Bénite, Rhône, France., Grou C; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada., Boudreau V; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada., Parent V; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada., Rakotoarisoa L; University of Strasbourg, INSERM UMR 1260, Department of Endocrinology and Diabetology, University Hospital of Strasbourg, Regenerative Nanomedicine Federation of Translational Medicine, Strasbourg, France., Girouard H; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada., Durieu I; Service de Médecine Interne et de Pathologie Vasculaire, Hospices Civils de Lyon, Hôpital Lyon Sud, 165 Chemin du Grand Revoyet, Pierre-Bénite, Rhône, France., Kessler L; University of Strasbourg, INSERM UMR 1260, Department of Endocrinology and Diabetology, University Hospital of Strasbourg, Regenerative Nanomedicine Federation of Translational Medicine, Strasbourg, France., Coriati A; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada; Department of Nutrition, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Research Centre of Hôpital du Sacré-Coeur de Montréal, Centre Intégré Universitaire de Santé et de Services Sociaux (CIUSSS) du Nord-de-l'Ile-de-Montréal, Montréal, Québec, Canada. Electronic address: adele.coriati@umontreal.ca.
Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2026 Mar; Vol. 25 (2), pp. 328-335. Date of Electronic Publication: 2025 Nov 18.
Publication Type: Journal Article; Observational Study; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41253584
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alexandre-Heymann+L%22">Alexandre-Heymann L</searchLink>; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Reynaud+Q%22">Reynaud Q</searchLink>; Service de Médecine Interne et de Pathologie Vasculaire, Hospices Civils de Lyon, Hôpital Lyon Sud, 165 Chemin du Grand Revoyet, Pierre-Bénite, Rhône, France.<br /><searchLink fieldCode="AU" term="%22Grou+C%22">Grou C</searchLink>; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Boudreau+V%22">Boudreau V</searchLink>; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Parent+V%22">Parent V</searchLink>; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Rakotoarisoa+L%22">Rakotoarisoa L</searchLink>; University of Strasbourg, INSERM UMR 1260, Department of Endocrinology and Diabetology, University Hospital of Strasbourg, Regenerative Nanomedicine Federation of Translational Medicine, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Girouard+H%22">Girouard H</searchLink>; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Durieu+I%22">Durieu I</searchLink>; Service de Médecine Interne et de Pathologie Vasculaire, Hospices Civils de Lyon, Hôpital Lyon Sud, 165 Chemin du Grand Revoyet, Pierre-Bénite, Rhône, France.<br /><searchLink fieldCode="AU" term="%22Kessler+L%22">Kessler L</searchLink>; University of Strasbourg, INSERM UMR 1260, Department of Endocrinology and Diabetology, University Hospital of Strasbourg, Regenerative Nanomedicine Federation of Translational Medicine, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Coriati+A%22">Coriati A</searchLink>; Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada; Department of Nutrition, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Research Centre of Hôpital du Sacré-Coeur de Montréal, Centre Intégré Universitaire de Santé et de Services Sociaux (CIUSSS) du Nord-de-l'Ile-de-Montréal, Montréal, Québec, Canada. Electronic address: adele.coriati@umontreal.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101128966%22">Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society</searchLink> [J Cyst Fibros] 2026 Mar; Vol. 25 (2), pp. 328-335. <i>Date of Electronic Publication: </i>2025 Nov 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101128966 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-5010 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215691993%22">15691993 </searchLink><i>NLM ISO Abbreviation: </i>J Cyst Fibros <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41253584
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jcf.2025.11.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 328
    Titles:
      – TitleFull: Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alexandre-Heymann L
      – PersonEntity:
          Name:
            NameFull: Reynaud Q
      – PersonEntity:
          Name:
            NameFull: Grou C
      – PersonEntity:
          Name:
            NameFull: Boudreau V
      – PersonEntity:
          Name:
            NameFull: Parent V
      – PersonEntity:
          Name:
            NameFull: Rakotoarisoa L
      – PersonEntity:
          Name:
            NameFull: Girouard H
      – PersonEntity:
          Name:
            NameFull: Durieu I
      – PersonEntity:
          Name:
            NameFull: Kessler L
      – PersonEntity:
          Name:
            NameFull: Coriati A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-5010
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
              Type: main
ResultId 1